CompletedNot Applicable

Er,Cr:YSGG Laser For Recipient Bed Bio-modification And Connective Tissue Harvesting in Treatment of Gingival Recession

Egypt24 participantsStarted 2015-02

Plain-language summary

A clinical and radiographic evaluation of using Erbium, Chromium, Scandium, Gallium and Garnet (Er,Cr:YSGG) laser in recipient site bio-modification and de-epithelialized connective tissue graft harvesting compared to conventional scalpel surgical technique in the treatment of class I and II Miller gingival recession.

Who can participate

Age range21 Years – 58 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Single class I, II Miller gingival recession defects (≥ 2mm in depth), presence of identifiable buccal cemento-enamel junction (CEJ) and presence of a step ≤ 1 mm at CEJ.
✓. Controlled periodontal disease
✓. Full-mouth plaque score of \<10%; full-mouth gingival score of \<15%
✓. Patients available for 9 months follow-up period.

Exclusion criteria

✕. Smokers.
✕. Pregnant and lactating females.
✕. Taking medications known to interfere with periodontal tissue health or healing.
✕. Previous periodontal surgery on the involved sites.
✕. Non-vital teeth.
✕. Molar teeth.
✕. Recession defects associated with caries or restoration.
✕. Occlusal interferences.

What they're measuring

Change in Recession depth

Timeframe: baseline-3-6-9 months

Trial details

NCT IDNCT03200392

SponsorMisr International University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2017-01

View on ClinicalTrials.gov More Gingival Recession, Localized trials